October isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…

Go here to discover the coin that could define this historic bull run with gains kicking off this mo

Kevin Waters Biography and Net Worth

EVP, CFO of PROCEPT BioRobotics

Mr. Waters has served as our EVP, Chief Financial Officer since January 2022. He previously served as our SVP, Chief Financial Officer from October 2018 until December 2021. Prior to joining PROCEPT BioRobotics Mr. Waters served as Chief Financial Officer at Accuray Inc., a radiation oncology company, from September 2015 to October 2018. In addition to his experience at Accuray, Inc., Mr. Waters held financial leadership positions at three publicly traded medical device companies, including Conceptus, Laserscope and VISX. These companies were all sold to strategic acquirers, generating approximately $3 billion in shareholder value. Mr. Waters began his career at PricewaterhouseCoopers, LLP. and received a B.S. in Business Administration, with a double concentration in Accounting and Finance from Cal Poly San Luis Obispo

What is Kevin Waters' net worth?: The estimated net worth of Kevin Waters is at least $6.95 million as of September 16th, 2024. Mr. Waters owns 96,096 shares of PROCEPT BioRobotics stock worth more than $6,948,702 as of October 11th. This net worth approximation does not reflect any other investments that Mr. Waters may own. Additionally, Mr. Waters receives an annual salary of $680,110.00 as EVP, CFO at PROCEPT BioRobotics. Learn More about Kevin Waters' net worth.
How old is Kevin Waters?: Mr. Waters is currently 47 years old. There are 5 older executives and no younger executives at PROCEPT BioRobotics. The oldest executive at PROCEPT BioRobotics is Dr. Reza Zadno Ph.D., President, CEO & Director, who is 69 years old. Learn More on Kevin Waters' age.
What is Kevin Waters' salary?: As the EVP, CFO of PROCEPT BioRobotics Co., Mr. Waters earns $680,110.00 per year. The highest earning executive at PROCEPT BioRobotics is Dr. Reza Zadno Ph.D., President, CEO & Director, who commands a salary of $1,130,000.00 per year. Learn More on Kevin Waters' salary.
How do I contact Kevin Waters?: The corporate mailing address for Mr. Waters and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Kevin Waters' contact information.
Has Kevin Waters been buying or selling shares of PROCEPT BioRobotics?: Kevin Waters has not been actively trading shares of PROCEPT BioRobotics during the last quarter. Most recently, Kevin Waters sold 25,000 shares of the business's stock in a transaction on Monday, September 16th. The shares were sold at an average price of $82.51, for a transaction totalling $2,062,750.00. Following the completion of the sale, the chief financial officer now directly owns 96,096 shares of the company's stock, valued at $7,928,880.96. Learn More on Kevin Waters' trading history.
Who are PROCEPT BioRobotics' active insiders?: PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.
Are insiders buying or selling shares of PROCEPT BioRobotics?: In the last twelve months, insiders at the sold shares 29 times. They sold a total of 564,842 shares worth more than $31,363,074.91. The most recent insider tranaction occured on September, 16th when CFO Kevin Waters sold 25,000 shares worth more than $2,062,750.00. Insiders at PROCEPT BioRobotics own 17.4% of the company. Learn More about insider trades at PROCEPT BioRobotics.
Information on this page was last updated on 9/16/2024.

Kevin Waters Insider Trading History at PROCEPT BioRobotics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/16/2024	Sell	25,000	$82.51	$2,062,750.00	96,096
3/18/2024	Sell	1,024	$48.83	$50,001.92	102,149
3/6/2024	Sell	3,435	$46.67	$160,311.45	49,416
2/12/2024	Sell	22,349	$50.16	$1,121,025.84	33,523
2/9/2024	Sell	28,677	$50.09	$1,436,430.93	33,523
2/7/2024	Sell	904	$50.00	$45,200.00	33,523
1/9/2024	Sell	17,310	$45.07	$780,161.70	33,523
12/13/2023	Sell	71,465	$40.05	$2,862,173.25	33,523
12/8/2023	Sell	6,888	$40.02	$275,657.76	33,523
12/6/2023	Sell	4,360	$40.02	$174,487.20	44,248
6/15/2023	Sell	22,631	$35.12	$794,800.72	33,523
3/16/2023	Sell	706	$31.84	$22,479.04	56,154
3/7/2023	Sell	7,954	$34.25	$272,424.50	56,860

Kevin Waters Buying and Selling Activity at PROCEPT BioRobotics

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Today's Range

Now: $73.48

$72.36

$73.79

50 Day Range

MA: $74.08

$56.31

$84.99

2 Week Range

Now: $73.48

$24.83

$85.81

Volume

76,201 shs

Average Volume

596,469 shs

Market Capitalization

$3.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Next opportunity for crypto millions

From Crypto 101 Media | Ad

Go here to discover the coin that could define this historic bull run with gains kicking off this mo

Kevin Waters Biography and Net Worth

What is Kevin Waters' net worth?

How old is Kevin Waters?

What is Kevin Waters' salary?

How do I contact Kevin Waters?

Has Kevin Waters been buying or selling shares of PROCEPT BioRobotics?

Who are PROCEPT BioRobotics' active insiders?

Are insiders buying or selling shares of PROCEPT BioRobotics?